Selected research
Market Structure
Global Corticosteroids Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Corticosteroids market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Corticosteroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Corticosteroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Corticosteroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Corticosteroids is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Corticosteroids include Sanofi, Johnson & Johnson, Novartis, Merck, Pfizer, GlaxoSmithKline, AstraZeneca, Sumitomo and Cipla, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Corticosteroids market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Corticosteroids and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Corticosteroids sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Corticosteroids market size, projected growth trends, production technologies, key applications, and end-use industries.
Corticosteroids Segment by Company
Sanofi
Johnson & Johnson
Novartis
Merck
Pfizer
GlaxoSmithKline
AstraZeneca
Sumitomo
Cipla
Corticosteroids Segment by Type
Cream
Injection
Other
Corticosteroids Segment by Application
Dermatology
Endocrinology
Allergy
Other
Corticosteroids Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Corticosteroids market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Corticosteroids and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Corticosteroids.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Corticosteroids market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Corticosteroids manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Corticosteroids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Corticosteroids in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cream
- Injection
- Other
Applications
- Dermatology
- Endocrinology
- Allergy
- Other
Companies covered
- Sanofi
- Johnson & Johnson
- Novartis
- Merck
- Pfizer
- GlaxoSmithKline
- AstraZeneca
- Sumitomo
- Cipla
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Corticosteroids Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Corticosteroids Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Corticosteroids Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Corticosteroids Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Corticosteroids Market Dynamics
- 2.1 Corticosteroids Industry Trends
- 2.2 Corticosteroids Industry Drivers
- 2.3 Corticosteroids Industry Opportunities and Challenges
- 2.4 Corticosteroids Industry Restraints
3 Corticosteroids Market by Manufacturers
- 3.1 Global Corticosteroids Revenue by Manufacturers (2021-2026)
- 3.2 Global Corticosteroids Sales by Manufacturers (2021-2026)
- 3.3 Global Corticosteroids Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Corticosteroids Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Corticosteroids Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Corticosteroids Manufacturers, Product Type & Application
- 3.7 Global Corticosteroids Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Corticosteroids Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Corticosteroids Players Market Share by Revenue in 2025
- 3.8.3 2025 Corticosteroids Tier 1, Tier 2, and Tier 3
4 Corticosteroids Market by Type
- 4.1 Corticosteroids Type Introduction
- 4.1.1 Cream
- 4.1.2 Injection
- 4.1.3 Other
- 4.2 Global Corticosteroids Sales by Type
- 4.2.1 Global Corticosteroids Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Corticosteroids Sales by Type (2021-2032)
- 4.2.3 Global Corticosteroids Sales Market Share by Type (2021-2032)
- 4.3 Global Corticosteroids Revenue by Type
- 4.3.1 Global Corticosteroids Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Corticosteroids Revenue by Type (2021-2032)
- 4.3.3 Global Corticosteroids Revenue Market Share by Type (2021-2032)
5 Corticosteroids Market by Application
- 5.1 Corticosteroids Application Introduction
- 5.1.1 Dermatology
- 5.1.2 Endocrinology
- 5.1.3 Allergy
- 5.1.4 Other
- 5.2 Global Corticosteroids Sales by Application
- 5.2.1 Global Corticosteroids Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Corticosteroids Sales by Application (2021-2032)
- 5.2.3 Global Corticosteroids Sales Market Share by Application (2021-2032)
- 5.3 Global Corticosteroids Revenue by Application
- 5.3.1 Global Corticosteroids Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Corticosteroids Revenue by Application (2021-2032)
- 5.3.3 Global Corticosteroids Revenue Market Share by Application (2021-2032)
6 Global Corticosteroids Sales by Region
- 6.1 Global Corticosteroids Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Corticosteroids Sales by Region (2021-2032)
- 6.2.1 Global Corticosteroids Sales by Region (2021-2026)
- 6.2.2 Global Corticosteroids Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Corticosteroids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Corticosteroids Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Corticosteroids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Corticosteroids Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Corticosteroids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Corticosteroids Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Corticosteroids Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Corticosteroids Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Corticosteroids Revenue by Region
- 7.1 Global Corticosteroids Revenue by Region
- 7.1.1 Global Corticosteroids Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Corticosteroids Revenue by Region (2021-2026)
- 7.1.3 Global Corticosteroids Revenue by Region (2027-2032)
- 7.1.4 Global Corticosteroids Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Corticosteroids Revenue (2021-2032)
- 7.2.2 North America Corticosteroids Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Corticosteroids Revenue (2021-2032)
- 7.3.2 Europe Corticosteroids Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Corticosteroids Revenue (2021-2032)
- 7.4.2 Asia-Pacific Corticosteroids Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Corticosteroids Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Corticosteroids Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi Corticosteroids Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Company Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Johnson & Johnson Corticosteroids Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Novartis
- 8.3.1 Novartis Company Information
- 8.3.2 Novartis Business Overview
- 8.3.3 Novartis Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Novartis Corticosteroids Product Portfolio
- 8.3.5 Novartis Recent Developments
- 8.4 Merck
- 8.4.1 Merck Company Information
- 8.4.2 Merck Business Overview
- 8.4.3 Merck Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Merck Corticosteroids Product Portfolio
- 8.4.5 Merck Recent Developments
- 8.5 Pfizer
- 8.5.1 Pfizer Company Information
- 8.5.2 Pfizer Business Overview
- 8.5.3 Pfizer Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Pfizer Corticosteroids Product Portfolio
- 8.5.5 Pfizer Recent Developments
- 8.6 GlaxoSmithKline
- 8.6.1 GlaxoSmithKline Company Information
- 8.6.2 GlaxoSmithKline Business Overview
- 8.6.3 GlaxoSmithKline Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 GlaxoSmithKline Corticosteroids Product Portfolio
- 8.6.5 GlaxoSmithKline Recent Developments
- 8.7 AstraZeneca
- 8.7.1 AstraZeneca Company Information
- 8.7.2 AstraZeneca Business Overview
- 8.7.3 AstraZeneca Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 AstraZeneca Corticosteroids Product Portfolio
- 8.7.5 AstraZeneca Recent Developments
- 8.8 Sumitomo
- 8.8.1 Sumitomo Company Information
- 8.8.2 Sumitomo Business Overview
- 8.8.3 Sumitomo Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Sumitomo Corticosteroids Product Portfolio
- 8.8.5 Sumitomo Recent Developments
- 8.9 Cipla
- 8.9.1 Cipla Company Information
- 8.9.2 Cipla Business Overview
- 8.9.3 Cipla Corticosteroids Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Cipla Corticosteroids Product Portfolio
- 8.9.5 Cipla Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Corticosteroids Value Chain Analysis
- 9.1.1 Corticosteroids Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Corticosteroids Production Mode & Process
- 9.2 Corticosteroids Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Corticosteroids Distributors
- 9.2.3 Corticosteroids Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst